2-BROMO-5-FLUOROPYRIDIN-4-OL, 95.0%, 5g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 5mg

2-Methylbenzo[d]thiazol-5-amine, 95.0%, 5g

1-Bromo-4-methoxy-2,5-dimethylbenzene, 98%, 10g

3-((Methylsulfonyl)methyl)aniline, 98%, 25g

1-Mesitylmethanamine, 97.0%, 25g

4,5,6-Trifluoropyrimidine, 96.0%, 1g

2-Chloro-1-(6-methoxypyridin-2-yl)ethanone, 95.0%, 100mg

N'-[2-(4-Chlorophenyl)-1-(2,2,2-trifluoroethylamino)ethylidene]hydrazinecarboxylic acid tert-butyl ester, 95.0%, 500mg

epsilon-Caprolactone>99.0%(GC)500mL

4-(3-Bromobenzyl)morpholine, 95+%, 5g

1-(2-Chloro-benzyl)-1 H -pyrazol-3-ylamine, 95.0%, 2g

(-)-Menthone>90.0%(GC)100mL